EUVIMEDEUVIMED entdecken
Crossref

Hypercoagulable and Autoimmune Factors in Patients with Moyamoya Syndrome

Justin F. Fraser, Ma, Min Jian Hoo, Christopher J. McLouth, Laura Whitnel, Lasslo, Jessica, Dornbos, Davis, Jill Roberts

UKnowledge (University of Kentucky) · 21.05.2025

DOI: 10.13023/neuro.data2025.01 ↗

Kurz gefasst

Fachartikel in der Zeitschrift UKnowledge (University of Kentucky), erschienen am 21.05.2025. Verfasst von Justin F. Fraser und 9 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Moyamoya is a progressive cerebrovascular condition leading to stenosis of the internal carotid arteries (ICA) and formation of abnormal vasculature at the base of the brain. Patients ultimately suffer from ischemic and/or hemorrhagic stroke. In Kentucky, patients often present with comorbidities, which classifies them as having moyamoya syndrome (MMS). In this prospective observational study, we measured coagulable- and autoimmune-related factors in MMS subjects to identify possible therapeutic targets and help inform clinical care. Venous blood samples were collected from adult subjects diagnosed with MMS and analyzed by the UK Healthcare Clinical Laboratory. Blood samples, demographics, and medical records were obtained following written consent and enrollment between July 2020 and February 2024. Thirty-one subjects were enrolled (20 females and 11 males) with a median age of 45 years and 64.5% residing in an Appalachian county. The majority of the subjects were obese (BMI >30) and 29.0% had type 2 diabetes. Elevated factor VIII levels were detected in half the subjects, with speckled antinuclear antibody (ANA), and abnormal erythrocyte sedimentation rates (ESR) also detected in a large portion of the subjects. Elevated levels of factor VIII may put them at risk of developing thrombosis and increased ischemia, while the increased inflammatory state and possible undiagnosed autoimmune reactivity may play an important role in the progression of the condition. Evaluation of these factors in MMS patients can help to inform clinical care and provide targets for a treatment strategy.

Schlagwörter

moyamoya syndromehypercoagulabilityautoimmune factorsfactor VIIIantinuclear antibodieserythrocyte sedimentation rateinternal carotid artery stenosisischemic strokehemorrhagic strokethrombosis risk

Zitieren

APA

Fraser, J. F., Ma, Hoo, M. J., McLouth, C. J., Whitnel, L., Lasslo, Jessica, Dornbos, Davis, & Roberts, J. (2025). Hypercoagulable and Autoimmune Factors in Patients with Moyamoya Syndrome. UKnowledge (University of Kentucky). https://doi.org/10.13023/neuro.data2025.01

Vancouver

Fraser JF, Ma, Hoo MJ, McLouth CJ, Whitnel L, Lasslo, et al. Hypercoagulable and Autoimmune Factors in Patients with Moyamoya Syndrome. UKnowledge (University of Kentucky). 2025. doi:10.13023/neuro.data2025.01

BibTeX
@article{Fraser2025,
  author = {Fraser, Justin F. and Ma and Hoo, Min Jian and McLouth, Christopher J. and Whitnel, Laura and Lasslo and Jessica and Dornbos and Davis and Roberts, Jill},
  title = {Hypercoagulable and Autoimmune Factors in Patients with Moyamoya Syndrome},
  journal = {UKnowledge (University of Kentucky)},
  year = {2025},
  doi = {10.13023/neuro.data2025.01}
}
Kostenlos starten →